Skip to main content
British Journal of Pharmacology and Chemotherapy logoLink to British Journal of Pharmacology and Chemotherapy
. 1958 Mar;13(1):65–70. doi: 10.1111/j.1476-5381.1958.tb00192.x

Inhibition by various substances of oedema formation in the hind-paw of the rat induced by 5-hydroxytryptamine, histamine, dextran, eggwhite and compound 48/80

J R Parratt, G B West
PMCID: PMC1481685  PMID: 13523137

Abstract

Of the substances studied for their inhibitory action of the oedema formation in the hind-paw of the rat, the most active was a new derivative of phenothiazine, related to chlorpromazine. It is methotrimeprazine {10-(3-dimethylamino-2-methylpropyl)-2-methoxyphenothiazine; 7044 RP}. This substance possesses potent antihistamine and anti-5-hydroxytryptamine properties, and doses of 0.25 mg./kg. inhibited the blueing and swelling of the foot after injections of histamine, 5-hydroxytryptamine, eggwhite, dextran or compound 48/80 into the feet of rats with sulphan blue (Evan's blue) dye in their circulation. The results indicate that both histamine and 5-hydroxytryptamine play rôles in increasing capillary permeability in the rat.

Full text

PDF
65

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENDITT E. P., ROWLEY D. A. Antagonism of 5-hydroxytryptamine by chlorpromazine. Science. 1956 Jan 6;123(3184):24–24. doi: 10.1126/science.123.3184.24. [DOI] [PubMed] [Google Scholar]
  2. GOZSY B., KATO L. Oedema formation in rat's skin. Nature. 1956 Dec 15;178(4546):1352–1352. doi: 10.1038/1781352a0. [DOI] [PubMed] [Google Scholar]
  3. HALPERN B. N., BRIOT M. Etude pathogénique et thérapeutique du syndrome oedèmateux provoqué chez le rat par l'ovalbumine. Arch Int Pharmacodyn Ther. 1950 May 1;82(3):247–296. [PubMed] [Google Scholar]
  4. PARRATT J. R., WEST G. B. 5-Hydroxytryptamine and the anaphylactoid reaction in the rat. J Physiol. 1957 Nov 14;139(1):27–41. doi: 10.1113/jphysiol.1957.sp005872. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. ROTHLIN E., CERLETTI A. Pharmacologic studies on a new antihistamine and its combination with calcium. Ann Allergy. 1955 Jan-Feb;13(1):80–89. [PubMed] [Google Scholar]
  6. ROWLEY D. A., BENDITT E. P. 5-Hydroxytryptamine and histamine as mediators of the vascular injury produced by agents which damage mast cells in rats. J Exp Med. 1956 Apr 1;103(4):399–412. doi: 10.1084/jem.103.4.399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. SHAW E. N., WOOLLEY D. W. Methylserotonins as potent antimetabolites of serotonin active both in vitro and in vivo. J Pharmacol Exp Ther. 1956 Feb;116(2):164–176. [PubMed] [Google Scholar]
  8. SPARROW E. M., WILHELM D. L. Species differences in susceptibility to capillary permeability factors: histamine, 5-hydroxytrytamine and compound 48/80. J Physiol. 1957 Jun 18;137(1):51–65. doi: 10.1113/jphysiol.1957.sp005795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. VIAUD P. Les amines derivées de la phenothiazine. J Pharm Pharmacol. 1954 Jun;6(6):361–389. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology and Chemotherapy are provided here courtesy of The British Pharmacological Society

RESOURCES